- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03429088
Exercise Promotion in Primary Care (EPPC)
August 30, 2021 updated by: Deborah R. Young, Kaiser Permanente
Exercise Promotion in Primary Care: Pilot Study
The investigators conducted a pilot study to determine if telephone counseling, in a health care setting that routinely assesses physical activity of its members, is a feasible approach to improve physical activity among patients with diabetes and prediabetes.
The investigators built on an existing innovation at Kaiser Permanente, in which physical activity is assessed at every outpatient visit.
The primary aims were to (1) pilot study elements, including database identification of patients; recruitment, training and engagement of health care providers; patient recruitment; data collection procedures; and a 24-week intervention, and (2) to assess feasibility and obtain feedback from key stakeholders on the approach.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
67
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 74 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- prediabetes or diabetes not prescribed insulin
- less than 30 min of physical activity per week
- cleared to increase physical activity by primary care provider
Exclusion Criteria:
- health condition that may limit unsupervised physical activity
- height and weight that were combined and resulted in a BMI > 40 kg/m2
- disabling rheumatoid or osteoarthritis
- ongoing treatment for cancer
- unstable coronary heart disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telephone counseling
Participants were provided with approximately 7 telephone-based motivational interviewing over a 24-week period to increase their physical activity.
|
|
|
No Intervention: Usual care
Participants in the usual care arm received a packet of places near their home in which they could engage in physical activity if they chose.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of identifying and recruiting sufficient number of participants into a telephone-based physical activity intervention.
Time Frame: The intervention lasted 24 weeks.
|
Participants who met eligibility criteria and who were scheduled for an outpatient visit with their primary care provider were invited to participate in the study.
Feasibility was assessed by the investigators' ability to recruit 60 participants into the pilot trial.
|
The intervention lasted 24 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Moderate to Vigorous Physical Activity
Time Frame: Assessments were made a baseline and approximately 24 weeks after baseline assessments.
|
Participants were mailed an Actigraph model 7185 accelerometer and asked to wear it over their right hip for 7 consecutive days and return the monitor through the mail.
Data were analyzed to assess daily moderate to vigorous physical activity using the Freedson cutpoints.
|
Assessments were made a baseline and approximately 24 weeks after baseline assessments.
|
|
Motivation for Physical Activity
Time Frame: Participants completed the survey at baseline and approximately 24 weeks after baseline assessments.
|
The 30-item Motivation for Physical Activities Measure was used to measure motivation for physical activity.
The scale has 5 factors: interest/enjoyment, competence, appearance, fitness, and social motivations.
A mean score for each factor was determined for each participant.
|
Participants completed the survey at baseline and approximately 24 weeks after baseline assessments.
|
|
Physical Activity Self-Regulation
Time Frame: Participants completed the survey at baseline and approximately 24 weeks after baseline.
|
This is a 16-item scale with the following factors: external regulation, introjected regulation, identified regulation, and intrinsic regulation.
A Relative Autonomy Index is formed from the factors, with the higher scores indicating greater autonomy toward physical activity.
|
Participants completed the survey at baseline and approximately 24 weeks after baseline.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2015
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
January 31, 2018
First Submitted That Met QC Criteria
February 5, 2018
First Posted (Actual)
February 12, 2018
Study Record Updates
Last Update Posted (Actual)
September 1, 2021
Last Update Submitted That Met QC Criteria
August 30, 2021
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KPSC IRB#10106
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
DiappyMedSanoiaRecruitingDiabetes Type 1 | Pancreatogenous Diabetes | Diabetes Type 2 on InsulinFrance
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
Clinical Trials on Motivational interviewing telephone counseling
-
Brown UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular DiseasesUnited States
-
Ohio University College of Osteopathic MedicineCompleted
-
Johns Hopkins UniversityZanvyl and Isabelle Krieger FundCompleted
-
University of NebraskaCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseCompleted
-
San Francisco Veterans Affairs Medical CenterCompletedSubstance-Related Disorders | Depression | Stress Disorders, Post-Traumatic | Combat DisordersUnited States
-
Université du Québec a MontréalCanadian Institutes of Health Research (CIHR)CompletedHigh-risk SexCanada
-
University of Cape TownVU University of AmsterdamUnknown
-
Ohio State UniversityCompletedObesity | OverweightUnited States
-
VA National Center for Rehabilitative Auditory...US Department of Veterans AffairsTerminated